Egypt vs Senegal: Population requiring preventive chemotherapy for schistosomiasis
Egypt
2.98 million
in 2023
Senegal
3.38 million
in 2024
Egypt rank
26th
Senegal rank
23rd
Population requiring preventive chemotherapy for schistosomiasis over time
- Egypt
- Senegal
How they compare
Senegal currently reports 3.38 million against 2.98 million in Egypt, a difference of 402,590.
That makes Senegal's figure about 1.1 times Egypt's.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Senegal ahead.
Egypt ranks 26th and Senegal ranks 23rd of 52 countries.
Across the 2 decades both report, Egypt averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Egypt | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.76 million | 3.81 million | 2.05 million | Senegal |
| 2020s | 2.94 million | 2.82 million | 123,732 | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Egypt or Senegal?
- Senegal, at 3.38 million against 2.98 million in Egypt as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Egypt and Senegal?
- 402,590, with Senegal ahead.
- How many years of comparable data are there for Egypt and Senegal?
- 14 years are reported by both, from 2010 to 2023.
- How do Egypt and Senegal rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Egypt ranks 26th and Senegal ranks 23rd of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.